Search Results - "Akse, M."
-
1
-
2
284P - Changes in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients
Published in Annals of oncology (01-10-2019)“…Despite ER positive IHC staining, some patients do not respond to neoadjuvant endocrine therapy, suggesting that ER staining lacks specificity to predict…”
Get full text
Journal Article -
3
-
4
-
5
284PChanges in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients
Published in Annals of oncology (01-10-2019)“…Abstract Background Despite ER positive IHC staining, some patients do not respond to neoadjuvant endocrine therapy, suggesting that ER staining lacks…”
Get full text
Journal Article